Thank you – I really enjoyed how you discussed the validity of the flange size research, looking at its strengths and weaknesses, and describing real world application.
Thank you — that was very interesting! Do smaller flanges increase the risk of discomfort with the nipple rubbing against the flange? Is that how you could know if the flange is too small?
There is an interesting article just came out recently: https://www.nature.com/articles/s41586-024-07634-3.
Is there a chance that in the future is will be screened? and we will be aboe to prevent PLO patient’s consequences?
I have mentioned before, there is a new amorphic Ca+ nano supplement (“Amorphical”), which is absorbed in a different way than any other ca supplements. Their in vivo+in vitro outcomes in osteopororsis and other bone related disease have been very interesting. I understand when the mechanism is not the ca but the PTH-rp etc, it is not the target solution, but worth a try to look up what happens when this is given a a larger and more powerful substrate (just like they did with VIT D here), and see if there are any differences in outcomes. I can facilitate the connection if you hear of anyone who wants to try 🙂
Heidi Hembry IBCLC
Thank you – I really enjoyed how you discussed the validity of the flange size research, looking at its strengths and weaknesses, and describing real world application.
Mirette
Great information
Maldabba
Thanks for the update ..it is helping for my clients.
Merry
Thank for update , helping my clients
Lisa Beck
Thank you!
Shannon
Love your podcast
Thank you
Sandy Stevenson, BNSc, RN, IBCLC
Thank you — that was very interesting! Do smaller flanges increase the risk of discomfort with the nipple rubbing against the flange? Is that how you could know if the flange is too small?
Anne Eglash
We discuss signs and symptoms of a too-small flange in our flange fitting video- https://www.youtube.com/watch?v=TpAnNNpRwx8&t=2s
Nedra Clark
Who are the authors of the Flange Fit Guide mentioned in the Podcast?
Anne Eglash
https://pubmed.ncbi.nlm.nih.gov/39614713/
Ofri Hayosh
There is an interesting article just came out recently: https://www.nature.com/articles/s41586-024-07634-3.
Is there a chance that in the future is will be screened? and we will be aboe to prevent PLO patient’s consequences?
I have mentioned before, there is a new amorphic Ca+ nano supplement (“Amorphical”), which is absorbed in a different way than any other ca supplements. Their in vivo+in vitro outcomes in osteopororsis and other bone related disease have been very interesting. I understand when the mechanism is not the ca but the PTH-rp etc, it is not the target solution, but worth a try to look up what happens when this is given a a larger and more powerful substrate (just like they did with VIT D here), and see if there are any differences in outcomes. I can facilitate the connection if you hear of anyone who wants to try 🙂